Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 74
13
Diseases
36
Unique genes
0.119
Avg. similarity score
Amino acid metabolism disorder
Most-connected disease (8 links)
Disease
Searched: lysinuric protein intolerance
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
lysinuric protein intolerance
Amino acid metabolism disorder
Urea cycle disorder
Citrullinemia
Hyperammonemia
ornithine translocase deficiency
Argininosuccinic aciduria
Citrin deficiency
ornithine carbamoyltransferase deficiency
Cystathioninuria
Hyperprolinemia
propionic acidemia
systemic lupus erythematosus, susceptibility to, 1
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Amino acid metabolism disorder | 8 | 8 | 26 |
| Urea cycle disorder | 7 | 7 | 8 |
| Citrullinemia | 4 | 4 | 3 |
| Hyperammonemia | 3 | 3 | 8 |
| ornithine translocase deficiency | 3 | 3 | 1 |
| Argininosuccinic aciduria | 2 | 2 | 1 |
| Citrin deficiency | 2 | 2 | 1 |
| ornithine carbamoyltransferase deficiency | 2 | 2 | 1 |
| Cystathioninuria | 1 | 1 | 1 |
| Hyperprolinemia | 1 | 1 | 2 |
| lysinuric protein intolerance | 1 | 1 | 1 |
| propionic acidemia | 1 | 1 | 2 |
| systemic lupus erythematosus, susceptibility to, 1 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SLC25A15 | 4 / 13 | Amino acid metabolism disorder, Citrullinemia, ornithine translocase deficiency, Urea cycle disorder |
| ASL | 3 / 13 | Amino acid metabolism disorder, Argininosuccinic aciduria, Urea cycle disorder |
| NAGS | 3 / 13 | Amino acid metabolism disorder, Hyperammonemia, Urea cycle disorder |
| OTC | 3 / 13 | Hyperammonemia, ornithine carbamoyltransferase deficiency, Urea cycle disorder |
| SLC25A13 | 3 / 13 | Citrin deficiency, Citrullinemia, Urea cycle disorder |
| ARG1 | 2 / 13 | Amino acid metabolism disorder, Urea cycle disorder |
| ASS1 | 2 / 13 | Citrullinemia, Urea cycle disorder |
| CPS1 | 2 / 13 | Hyperammonemia, Urea cycle disorder |
| CTH | 2 / 13 | Amino acid metabolism disorder, Cystathioninuria |
| PCCA | 2 / 13 | Amino acid metabolism disorder, propionic acidemia |
| PCCB | 2 / 13 | Amino acid metabolism disorder, propionic acidemia |
| PRODH | 2 / 13 | Amino acid metabolism disorder, Hyperprolinemia |
| SLC7A7 | 2 / 13 | Amino acid metabolism disorder, lysinuric protein intolerance |
| TLR5 | 2 / 13 | Hyperammonemia, systemic lupus erythematosus, susceptibility to, 1 |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Urea cycle | Reactome | 7 / 10 | 234× | 1.39e-16 | 5.67e-14 ✓ sig. |
| Biosynthesis of amino acids | KEGG | 10 / 75 | 44.5× | 1.08e-14 | 3.05e-12 ✓ sig. |
| Arginine biosynthesis | KEGG | 7 / 23 | 102× | 2.77e-13 | 6.01e-11 ✓ sig. |
| Metabolic pathways | KEGG | 22 / 1,563 | 4.7× | 1.75e-11 | 2.78e-9 ✓ sig. |
| Carbon metabolism | KEGG | 7 / 115 | 20.3× | 4.07e-8 | 2.86e-6 ✓ sig. |
| Alanine, aspartate and glutamate metabolism | KEGG | 5 / 37 | 45.1× | 7.37e-8 | 4.85e-6 ✓ sig. |
| Valine, leucine and isoleucine degradation | KEGG | 5 / 48 | 34.8× | 2.83e-7 | 1.56e-5 ✓ sig. |
| Cysteine and methionine metabolism | KEGG | 5 / 52 | 32.1× | 4.26e-7 | 2.23e-5 ✓ sig. |
| One carbon pool by folate | KEGG | 4 / 38 | 35.1× | 4.67e-6 | 1.74e-4 ✓ sig. |
| Glycine, serine and threonine metabolism | KEGG | 4 / 40 | 33.4× | 5.75e-6 | 2.06e-4 ✓ sig. |
| Arginine and proline metabolism | KEGG | 4 / 50 | 26.7× | 1.42e-5 | 4.36e-4 ✓ sig. |
| Proline catabolism | Reactome | 2 / 3 | 222× | 2.62e-5 | 7.32e-4 ✓ sig. |
| Propionyl-CoA catabolism | Reactome | 2 / 5 | 133× | 8.69e-5 | 1.95e-3 ✓ sig. |
| Propanoate metabolism | KEGG | 3 / 32 | 31.3× | 1.16e-4 | 2.45e-3 ✓ sig. |
| Sulfur amino acid metabolism | Reactome | 2 / 6 | 111× | 1.30e-4 | 2.70e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| urea cycle | GO:0000050 | 7 / 12 | 303× | 4.16e-17 | 4.17e-14 ✓ sig. |
| amino acid biosynthetic process | GO:0008652 | 6 / 27 | 115× | 9.48e-12 | 3.50e-9 ✓ sig. |
| L-arginine biosynthetic process | GO:0006526 | 4 / 4 | 519× | 1.16e-11 | 4.21e-9 ✓ sig. |
| response to zinc ion | GO:0010043 | 4 / 27 | 76.9× | 1.97e-7 | 2.13e-5 ✓ sig. |
| midgut development | GO:0007494 | 3 / 8 | 195× | 3.65e-7 | 3.57e-5 ✓ sig. |
| glutamine metabolic process | GO:0006541 | 3 / 15 | 104× | 2.94e-6 | 1.97e-4 ✓ sig. |
| L-arginine biosynthetic process via ornithine | GO:0042450 | 2 / 2 | 519× | 3.61e-6 | 2.33e-4 ✓ sig. |
| monoatomic anion homeostasis | GO:0055081 | 2 / 2 | 519× | 3.61e-6 | 2.33e-4 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 6 / 248 | 12.6× | 7.18e-6 | 4.05e-4 ✓ sig. |
| proline metabolic process | GO:0006560 | 2 / 3 | 346× | 1.08e-5 | 5.58e-4 ✓ sig. |
| L-proline catabolic process to L-glutamate | GO:0010133 | 2 / 3 | 346× | 1.08e-5 | 5.58e-4 ✓ sig. |
| cellular response to oleic acid | GO:0071400 | 2 / 3 | 346× | 1.08e-5 | 5.58e-4 ✓ sig. |
| short-chain fatty acid catabolic process | GO:0019626 | 2 / 3 | 346× | 1.08e-5 | 5.58e-4 ✓ sig. |
| L-proline catabolic process | GO:0006562 | 2 / 4 | 260× | 2.16e-5 | 9.60e-4 ✓ sig. |
| trans-4-hydroxy-L-proline catabolic process | GO:0019470 | 2 / 4 | 260× | 2.16e-5 | 9.60e-4 ✓ sig. |